The company is consolidating cell therapy, gene therapy and oncology research from Seattle to sites in South San Francisco ...
Here's a fuller look at what's now a $430 million-plus master plan with apartments, a luxury hotel and offices in the Crossroads Arts District.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results